Research reveals that oxidative stress modulation of vdac enhances t-cells in tumor immunotherapy, suggesting intervention strategies.
Description T-cell metabolic fitness is crucial for their effectiveness in tumor immunotherapy, influencing proliferation, survival, and function. Enhancing mitochondrial performance is a promising strategy to improve therapeutic outcomes. Voltage-dependent anion channels (VDACs) in the mitochondrial outer membrane regulate energy metabolism, apoptosis, and calcium homeostasis. We hypothesized that VDAC oligomerization, particularly under oxidative stress, significantly impacts T-cell states, thereby presenting opportunities for intervention. We investigated modulating VDAC oxidation through small molecules and genetic approaches using mouse T cells and human PBMCs. Novel inhibitors targeting VDAC oxidation and genetic models with VDAC1 mutations were developed. Vdac-1-deficient T cells exhibited enhanced expansion and a central memory phenotype. Pharmacological and genetic VDAC1 inhibition promoted memory-like subsets with increased memory-associated gene expression and fewer exhaustion markers. In human T cells, VDAC oxidation inhibition reduced exhaustion. Mice expressing the VDAC1C127A mutation exhibited lower oxidative stress and fewer exhausted T cells, highlighting the importance of this residue in regulating T-cell fitness. These findings underscore VDAC proteins as key oxidative stress regulators and suggest targeting VDAC oxidation as a novel strategy to enhance T-cell efficacy in tumor immunotherapy. Funding Sources This study was funded by the Intramural NIH funds.
No takes yet. Share an insight, caveat, or question.
Gurusamy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: